AlzeCure Pharma AB (publ) (AC6.F)

0.1205 -0.0150 (-11.07%) As of 10:18AM CEST. Market open.

AlzeCure Pharma AB (publ)

Hälsovägen 7
Floor 7 Novum, Elevator D
Huddinge 141 57
Sweden
46 7 63 16 24 77
https://www.alzecurepharma.se

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 11

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Martin Jönsson	Chief Executive Officer	2.41M	N/A	1968
Ms. Birgitta Lundvik	Chief Financial Officer	N/A	N/A	1967
Mr. Johan Sandin	Chief Scientific Officer	1.28M	N/A	1970
Dr. Marta Segerdahl Storck M.D., Ph.D.	Chief Medical Officer & Head of Development	N/A	N/A	1956
Mr. Pontus Forsell	Head of Research & Discovery	N/A	N/A	1967

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

AlzeCure Pharma AB (publ), a pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is developing drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its pipeline products include ACD856, which is in phase I clinical trial to treat Alzheimer's disease, sleep disorders, traumatic brain injuries, and Parkinson's disease; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer's disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain; and TrkA-NAM for osteoarthritic pain. The company was founded in 2012 and is based in Huddinge, Sweden.

Corporate Governance

AlzeCure Pharma AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.